$1.39
-0.14-9.15%
al cierre: Nov 18, 4:00 PM EST
$1.40
-0.13-8.5%
Premercado: 7:09 AM EST
Altimmune (ALT) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q3 | Nov 12, 2026 | $-0.15 | $-0.14 | -7.14 % |
| Q2 | Aug 12, 2026 | $-0.12 | $-0.13 | 7.69 % |
| Q1 | May 13, 2026 | $-0.18 | $-0.25 | 28.0 % |
| Q4 | Mar 5, 2026 | $-0.27 | $-0.25 | -8.00 % |
Quarterly Revenue (Billions)
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q3 | Nov 12, 2026 | $0 | $1.40K | -100.0 % |
| Q2 | Aug 12, 2026 | $0 | $1.40K | -100.0 % |
| Q1 | May 13, 2026 | $0 | $1.00K | -100.0 % |
| Q4 | Mar 5, 2026 | $26.00K | $560.00 | 4542.9 % |
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.14 | $-0.13 | $-0.25 | $-0.25 |
| Actual | $-0.15 | $-0.12 | $-0.18 | $-0.27 |
| Surprise | -7.14% | +7.69% | +28.0% | -8.00% |
| Revenue | ||||
| Estimate | $1400 | $1400 | $1000 | $560 |
| Actual | $0 | $0 | $0 | $26000 |
| Surprise | -100.0% | -100.0% | -100.0% | +4542.9% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.18 | $-0.16 | $-0.15 | $-0.16 |
| Revenue | ||||
| Consensus | — | — | — | — |
